Our
Clients
: Aug, 2020
: 100
:
Genomics Market: Description
Genomics is a multidisciplinary arena of genetics concentrating on the structure, function, evolution, mapping, and editing of genomes. A genome is a complete set of DNA of a life form that consists of each of its qualities and a three-dimensional structural configuration. Essentially, every solitary cell in the human body comprises of a complete copy of roughly, 3 million DNA base pairs, or letters that constitute a human genome. With its four-letter lingo, DNA possesses the entire information of the anatomy of humans. It carries a set of commands for making a specific protein or set of proteins. Every estimated 20,000 to 25,000 genes of the genome create roughly three proteins.
Genomes, located on 23 pairs of chromosomes compressed with the nucleus of human cells, instruct the production of a protein with the assistance of enzymes and molecules. The enzymes copy the information in the genes DNA and transfer it to the molecule recognized as mRNA (messenger ribonucleic acid). The mRNA travels out of the nucleus, into the cells cytoplasm, where the mRNA is read by a tiny molecule called ribosome. This information is used to link together small molecules called amino acids in order to form a specific protein. Proteins make up body structures such as organs and tissues, as well as control chemical reactions and carry signals between cells.
Genomics consists the ability to prevent, manage, and treat the diseases. The health care sector is gradually developing from traditional treatment methods to precision medicine and has pivoted this transition through exceptional clinical properties in past few years. Alongside, genome engineering has risen as a useful mechanism for the diagnosis of critical disease such as cancer.
Source: WMR
Genomics Market: Overview
The Genomics Market is set to demonstrate a substantial upswing of a CAGR of 19.40% during the forecasted period of 2023 to 2033. The Genomics Market was valued at USD 23,500 million in 2022 and is estimated to display a significant improvement to reach USD 137,160 million by 2033.
Genomics is the study of human genes (the genome), along with the interactions of the genes with each other. A comprehensive set of organisms DNA is alluded as Genome. Virtually, every single cell in human body consists of a whole replica of around 3 million DNA base pairs. The DNA has its own four-lettered language which when translated leads to the myriad of proteins that mark us who we are as a species and as individuals. The technological advancement in the field of genome by the key players and availability of wide range of genome products utilised in COVID-19 study helped researchers to gain better know-how of the recent corona virus. The primary factors contributing the growth are rising government support, growing number of genomics studies, falling sequencing cost, increased genomics end users etc. The genomics market is geared to attain aggressive growth, as a result of crucial genetic developments and their application in several therapeutic studies. These include intra-genomic phenomena, like epistasis, heterosis, pleiotropy, and many more.
Bio-engineering and synthetic biology applications are further anticipated to boost Genomics Market growth. In addition to this, humongous investments made by governmental bodies across the globe for the research and developments in genomics studies is boosting Genomics Market. For instance, in January 2020, the Department of Biotechnology (DBT) introduced the Genome India Project (GIP) in India. Under this project around 10,000 genetic Indian samples will be collected to create a reference genome. The
main aim of this project is to build reference genome for mutation spectrum of genetic and complex diseases, rare genetic disorders, genetic epidemiology of multifactorial lifestyle diseases, and translational research project. Such initiatives are expected to drive Genomics Market.
Source: WMR
Genomics Market: Key Trends
Rising government funding for genome projects is propelling Genomics Market.
One of the prominent aspects boosting the growth is growing administrative initiative in the research and development of genome projects. Genomic study is an essential tool that can assist the development of effective therapies. For example, the Genomics England collaborated with NHS has initiated Genomic Service that assimilated the entire genome routine medical care. In addition to this, there are several projects conducted across the globe. The data generated through these projects is expected to accelerate forthcoming human genetics research with better precision. This will be favourable for Genomics Market.
Emergence of new products and innovative services to favour the growth
Consumers shift from traditional consumption of medicines to patient specific medicines along with decreased cost of sequencing with respect to introduction of NGS (next-generation sequencing) technology, have yielded several new products and services. The genome market is gradually getting more competitive, with new player entering Genomics Market. Thus, companies are now introducing advanced products and services to maintain Genomics Market position. For illustration, in July 2020, Illumina, an American based company, announced the commencement of e-TruSight Software Suite and provided ready-to-use infrastructure for the complete genome sequencing that is used to describe genetic diseases. This is expected to boost Genomics Market. However, certain factors such as the high cost of the equipment and consumables, the shortage of skilled professionals, are expected to impact market growth.
Covid-19 Impact On Market
With the progress of innovative genome technologies by the influencers of Genomics Market and a wide range of genomic products used in COVID-19 research, helped the scientists to gain better understanding of coronavirus. Thus, the recent pandemic has positively impacted Genomics Market, as scientists tried to discourse the genetic severity and susceptibility of SARS-CoV-2 infection by applying the existing genetic databases. Moreover, the data acquired from genomes such as ABO blood groups, polygenic risk scores (PRS) can be theoretically used to decode COVID-19 susceptibility, complications, and resistance. The recent pandemic that hit the world badly and completely changed management of health care sector. Both government and pharmaceutical sector as well as biotechnology sector have augmented their research and development activities and increased their investments to formulate an efficient vaccine or treatment against Covid-19. Efforts to study genetic structure of Covid -19 has increased drastically which has the boosted Genomics Market.
Genomics Market: Segmentation Analysis
Genomics Market based on Products and Services
Products
o Instruments/Systems/Software
o Consumables & Reagents
Services
o NGS-based Services
o Core Genomics Services
o Biomarker Translation Services
o Computational Services
o Others
Among the deliverables segment the products category was dominant factor with a revenue share of 65.0%.
Source: WMR
Genomics Market by End Use:
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Academic and Government Institutes
Clinical Research
Other
Genomics Market: Regional Segmentation Analysis
Based on the geographical view, Genomics Market occupies regions such as
North America
Europe
Asia-Pacific
Middle-East and Africa.
North America ruled Genomics Market with a revenue share of 36.7% by a reason of a surge in the number of research projects and a high number of strategic partnerships.
Genomics Market: Competitive Landscape
Companies are focusing on development of new products and collaboration with other entities to rise Genomics Market share. The main purpose of this collaboration is to manage the work flows. Some of the prominent companies are Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Oxford Nanopore technologies, Danaher corporation, BGI (Beijing Genomics Institute), IntegraGen, GE HEalthcare, Pacific Bioscience of california, Inc., Quest Diagnostics, Myriad Genetics, Inc., Eppendorf AG, Eurofins Scientific, Others.
Report Scope:
Genomics Market Forecast Years: 2021-2030
Genomics Market Historical Years: 2018-2021
Genomics Market 2021: USD 23.5 million
Genomics Market 2030: USD 137.16 million
Genomics Market CAGR: 19.40%
Key Segments: Deliverable, Application & Technology, End use and Region
Key Regions & Countries: North America; Europe; Asia Pacific; Latin America; MEA.
Key Players: Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Oxford Nanopore technologies, Danaher corporation, BGI (Beijing Genomics Institute), IntegraGen, GE HEalthcare, Pacific Bioscience of california, Inc., Quest Diagnostics, Myriad Genetics, Inc., Eppendorf AG, Eurofins Scientific, Others.
1. Global Genomics Market Introduction and Market Overview
1.1. Objective of the Market Research Study
1.2. GENOMICS Market Definition & Description
1.3. Research Data Parameters & Reporting Timelines
1.3.1. Historical Data Reporting Years 2020 to 2021
1.3.2. Projected Data Reporting Years 2022 to 2033
1.3.3. Reporting Data Parameters Value (US$ Million)
1.4. Global GENOMICS Market Scope and Market Estimation
1.4.1. Global GENOMICS Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)
1.4.2. Global GENOMICS Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033
1.5. GENOMICS Market Segmentation
1.5.1. Product & Service of Global GENOMICS Market
1.5.2. Technology of Global GENOMICS Market
1.5.3. Application of Global GENOMICS Market
1.5.4. End User of Global GENOMICS Market
1.5.5. Key Regions of Global GENOMICS Market
2. Global GENOMICS Market - Executive Summary
2.1. Global GENOMICS Market Summary & Snapshot
2.2. Global GENOMICS Market, By Product & Service (US$ Million)
2.3. Global GENOMICS Market, By Technology (US$ Million)
2.4. Global GENOMICS Market, By Application (US$ Million)
2.5. Global GENOMICS Market, By End User (US$ Million)
2.6. Global GENOMICS Market, By Geography (US$ Million)
2.7. Global GENOMICS Market Outlook & Future Opportunities
3. Global GENOMICS Market Trends, Outlook, and Factors Analysis
3.1. Global GENOMICS Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global GENOMICS Market Industry Development
3.1.3. Pre & Post COVID-19 Trends and Scenarios
3.2. Market Dynamics (Growth Impacting Factors & Rationales)
3.2.1. Drivers
3.2.1.1. Increasing government funding to support genomics projects
3.2.1.2. Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
3.2.2. Restraints
3.2.2.1. High cost of genomic equipment
3.2.2.2. Dearth of trained professionals
3.2.3. Opportunities
3.2.3.1. Use of genomics in specialized/personalized medicine
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porters Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Average Selling Prices and Pricing Trends Analysis of GENOMICS Market
3.8. Technological Roadmap
3.9. Key Investment Pockets of GENOMICS Market
3.9.1. By Product & Service
3.9.2. By Technology
3.9.3. By Application
3.9.4. By End User
3.9.5. By Regions
4. Global GENOMICS Market: Estimates & Historic Trend Analysis (2020 to 2021)
4.1. Global GENOMICS Market, 2020 2021 (US$ Million)
4.2. Global GENOMICS Market, By Product & Service, 2020 to 2021 (US$ Million)
4.3. Global GENOMICS Market, By Technology, 2020 to 2021 (US$ Million)
4.4. Global GENOMICS Market, By Application, 2020 to 2021 (US$ Million)
4.5. Global GENOMICS Market, By End User, 2020 to 2021 (US$ Million)
4.6. Global GENOMICS Market, By Region, 2020 to 2021 (US$ Million)
5. Global GENOMICS Market Estimates & Forecast Trend Analysis, by Product & Service
5.1. Global GENOMICS Market Share (%) Estimates and Forecasts, by Product & Service, 2022 & 2033
5.2. Global GENOMICS Market Size (US$ Million) Estimates and Forecasts, by Product & Service, 2022 to 2033
5.2.1. Systems & Software
5.2.2. Consumables
5.2.3. Services
6. Global GENOMICS Market Estimates & Forecast Trend Analysis, by Technology
6.1. Global GENOMICS Market Share (%) Estimates and Forecasts, by Technology, 2022 & 2033
6.2. Global GENOMICS Market (US$ Million) Estimates and Forecasts, by Technology, 2022 to 2033
6.2.1. Sequencing
6.2.2. PCR
6.2.3. Nucleic Acid Extraction and Purification
6.2.4. Microarray
6.2.5. Other Technologies
Global GENOMICS Market Estimates & Forecast Trend Analysis, by Application
6.3. Global GENOMICS Market Share (%) Estimates and Forecasts, by Application, 2022 & 2033
6.4. Global GENOMICS Market Size (US$ Million) Estimates and Forecasts, by Application, 2022 to 2033
6.4.1. Drug Discovery and Development
6.4.2. Diagnostics
6.4.3. Agriculture and Animal Research
6.4.4. Other Applications
7. Global GENOMICS Market Estimates & Forecast Trend Analysis, by End User
7.1. Global GENOMICS Market Share (%) Estimates and Forecasts, by End User, 2022 & 2033
7.2. Global GENOMICS Market (US$ Million) Estimates and Forecasts, by End User, 2022 to 2033
7.2.1. Hospitals & Clinics
7.2.2. Research Centers and Academic & Government Institutes,
7.2.3. Pharmaceutical & Biotechnology Companies
7.2.4. Other End Users
8. Global GENOMICS Market Analysis and Forecast, by Region
8.1. Global GENOMICS Market Share (%) Estimates and Forecasts, by Region, 2022 & 2033
8.2. Global GENOMICS Market (US$ Million) Estimates and Forecasts, by Region, 2022 to 2033
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Middle East and Africa
8.2.5. Latin America
9. North America GENOMICS Market: Estimates & Forecast Trend Analysis
9.1. North America GENOMICS Market Assessments & Key Findings
9.2. North America GENOMICS Market Share (%) Estimates and Forecasts, 2022 & 2033
9.3. North America GENOMICS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
9.3.1. By Product & Service
9.3.2. By Technology
9.3.3. By Application
9.3.4. By End User
9.3.5. By Major Country
9.3.5.1. The U.S.
9.3.5.2. Canada
10. Europe GENOMICS Market: Estimates & Forecast Trend Analysis
10.1. Europe GENOMICS Market Assessments & Key Findings
10.2. Europe GENOMICS Market Share (%) Estimates and Forecasts, 2022 & 2033
10.3. Europe GENOMICS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
10.3.1. By Product & Service
10.3.2. By Technology
10.3.3. By Application
10.3.4. By End User
10.3.5. By Major Country
10.3.5.1. Germany
10.3.5.2. The U.K.
10.3.5.3. France
10.3.5.4. Italy
10.3.5.5. Spain
10.3.5.6. Rest of Europe (includes all other European countries)
11. Asia Pacific GENOMICS Market: Estimates & Forecast Trend Analysis
11.1. Asia Pacific GENOMICS Market Assessments & Key Findings
11.2. Asia Pacific GENOMICS Market Share (%) Estimates and Forecasts, 2022 & 2033
11.3. Asia Pacific GENOMICS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
11.3.1. By Product & Service
11.3.2. By Technology
11.3.3. By Application
11.3.4. By End User
11.3.5. By Major Country
11.3.5.1. China
11.3.5.2. Japan
11.3.5.3. India
11.3.5.4. ASEAN
11.3.5.5. South Korea
11.3.5.6. Rest of Asia Pacific (includes all other Asia Pacific countries)
12. Middle East & Africa GENOMICS Market: Estimates & Forecast Trend Analysis
12.1. Middle East & Africa GENOMICS Market Assessments & Key Findings
12.2. Middle East & Africa GENOMICS Market Share (%) Estimates and Forecasts, 2022 & 2033
12.3. Middle East & Africa GENOMICS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
12.3.1. By Product & Service
12.3.2. By Technology
12.3.3. By Application
12.3.4. By End User
12.3.5. By Major Country
12.3.5.1. GCC
12.3.5.2. South Africa
12.3.5.3. Egypt
12.3.5.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)
13. Latin America GENOMICS Market: Estimates & Forecast Trend Analysis
13.1. Latin America Market Assessments & Key Findings
13.2. Latin America GENOMICS Market Share (%) Estimates and Forecasts, 2022 & 2033
13.3. Latin America GENOMICS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
13.3.1. By Product & Service
13.3.2. By Technology
13.3.3. By Application
13.3.4. By End User
13.3.5. By Major Country
13.3.5.1. Brazil
13.3.5.2. Mexico
13.3.5.3. Rest of Latin America (includes all other Latin America countries)
14. Competitive Landscape
14.1. Market Revenue Share Analysis (%), by Major Players (2021)
14.2. Market Competition Matrix, by Leading Players
14.3. List of Emerging, Prominent and Leading Players
14.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, etc.
15. Company Profiles
15.1. Illumina, Inc.
15.1.1. Company Overview & Insights
15.1.2. Financial Performance
15.1.3. Product & Service / Service Portfolio
15.1.4. Geographical Footprint & Share
15.1.5. Strategic Initiatives & Key Developments
*Similar details would be provided for all the players mentioned below
15.2. Thermo Fisher Scientific
15.3. QIAGEN N.V.
15.4. Agilent Technologies, Inc.
15.5. F. Hoffmann-La Roche Ltd.
15.6. Bio-Rad Laboratories, Inc.
15.7. Oxford Nanopore technologies
15.8. Danaher corporation
15.9. BGI (Beijing Genomics Institute)
15.10. IntegraGen
15.11. GE HEalthcare
15.12. Pacific Bioscience of california, Inc
15.13. Quest Diagnostics
15.14. Myriad Genetics, Inc.
15.15. Eppendorf AG
15.16. Eurofins Scientific
15.17. Others
16. Assumptions and Research Methodology
16.1. Data Mining
16.2. Secondary Research
16.3. Primary Research
16.4. Subject Matter Expert Advice
16.5. Quality Check
16.6. Final Review
16.7. Data Triangulation
16.8. Bottom-Up Approach
16.9. Top Down Approach
16.10. Research Flow
16.11. Key Insights from Industry Experts
16.12. Data Sources
16.13. Assumptions
16.14. Limitations
17. Conclusions and Recommendations
17.1. Key Research Findings and Conclusion
17.2. Key Insights & Recommendations from Analysts